Globus Medical Inc (GMED) stock
GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$70.53+0.54 (+0.77%)
Close on Nov 18, 2026Market cap $9.47BP/E 18.0Yield –
Globus Medical total assets
Total assets on the balance sheet at the end of each period.
Globus Medical's total assets was $5.49B at Jun 30, 2026. For fiscal 2025 it was $5.30B, up 1.0% from the year before. Over ten years it grew 20.3% a year on average. The highest annual figure on record is $5.30B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.30B | +1.0% |
| FY2024 | Dec 31, 2024 | $5.25B | +3.3% |
| FY2023 | Dec 31, 2023 | $5.09B | +145.0% |
| FY2022 | Dec 31, 2022 | $2.08B | +6.1% |
| FY2021 | Dec 31, 2021 | $1.96B | +16.5% |
| FY2020 | Dec 31, 2020 | $1.68B | +9.6% |
| FY2019 | Dec 31, 2019 | $1.53B | +17.8% |
| FY2018 | Dec 31, 2018 | $1.30B | +20.6% |
| FY2017 | Dec 31, 2017 | $1.08B | +16.3% |
| FY2016 | Dec 31, 2016 | $927.64M | +11.2% |
| FY2015 | Dec 31, 2015 | $834.10M | +18.6% |
| FY2014 | Dec 31, 2014 | $703.55M | +24.2% |
| FY2013 | Dec 31, 2013 | $566.30M | +26.7% |
| FY2012 | Dec 31, 2012 | $447.13M | +35.7% |
| FY2011 | Dec 31, 2011 | $329.39M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.49B | +10.6% |
| Q1 FY2026 | Mar 31, 2026 | $5.44B | +15.5% |
| Q4 FY2025 | Dec 31, 2025 | $5.30B | +1.0% |
| Q3 FY2025 | Sep 30, 2025 | $5.10B | +0.2% |
| Q2 FY2025 | Jun 30, 2025 | $4.96B | -0.7% |
| Q1 FY2025 | Mar 31, 2025 | $4.71B | -4.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.25B | +3.3% |
| Q3 FY2024 | Sep 30, 2024 | $5.09B | -5.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.99B | +125.7% |
| Q1 FY2024 | Mar 31, 2024 | $4.94B | +130.0% |
| Q4 FY2023 | Dec 31, 2023 | $5.09B | +145.0% |
| Q3 FY2023 | Sep 30, 2023 | $5.36B | +171.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.21B | +15.6% |
| Q1 FY2023 | Mar 31, 2023 | $2.15B | +7.6% |
| Q4 FY2022 | Dec 31, 2022 | $2.08B | +6.1% |
| Q3 FY2022 | Sep 30, 2022 | $1.98B | +3.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.91B | +4.6% |
| Q1 FY2022 | Mar 31, 2022 | $2.00B | +15.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.96B | +16.5% |
| Q3 FY2021 | Sep 30, 2021 | $1.91B | +23.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.83B | +24.9% |
| Q1 FY2021 | Mar 31, 2021 | $1.74B | +17.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.68B | +9.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.54B | +6.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.47B | +5.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.48B | +10.7% |
| Q4 FY2019 | Dec 31, 2019 | $1.53B | +17.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.45B | +17.3% |
| Q2 FY2019 | Jun 30, 2019 | $1.39B | +16.5% |
| Q1 FY2019 | Mar 31, 2019 | $1.34B | +18.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.30B | +20.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.24B | +19.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.19B | +20.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.13B | +17.4% |
| Q4 FY2017 | Dec 31, 2017 | $1.08B | +16.3% |
| Q3 FY2017 | Sep 30, 2017 | $1.04B | +15.0% |
| Q2 FY2017 | Jun 30, 2017 | $995.01M | – |
| Q1 FY2017 | Mar 31, 2017 | $960.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $927.64M | – |
| Q3 FY2016 | Sep 30, 2016 | $901.74M | – |
See a number that looks wrong?